Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata

Brain Res. 1997 Oct 3;770(1-2):72-80. doi: 10.1016/s0006-8993(97)00757-9.

Abstract

The hallmark of Alzheimer's disease is the cerebral deposition of amyloid which is derived from the amyloid precursor protein (APP). The function of APP is unknown but there is increasing evidence for the role of APP in cell-cell and/or cell-matrix interactions. Primary cultures of murine neurons were treated with antisense oligonucleotides to down-regulate APP. This paper presents evidence that APP mediates a substrate-specific interaction between neurons and extracellular matrix components collagen type I, laminin and heparan sulphate proteoglycan but not fibronectin or poly-L-lysine. It remains to be determined whether this effect is the direct result of APP-matrix interactions, or whether an intermediatry pathway is involved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Protein Precursor / genetics*
  • Amyloid beta-Protein Precursor / metabolism*
  • Amyloid beta-Protein Precursor / pharmacology
  • Animals
  • Animals, Newborn
  • Antisense Elements (Genetics) / pharmacology
  • Cell Adhesion / drug effects
  • Cell Adhesion / physiology
  • Cell Survival / physiology
  • Cells, Cultured
  • Cerebral Cortex / cytology
  • Culture Media
  • Extracellular Matrix / metabolism
  • Ganglia, Spinal / cytology
  • Mice
  • Neurites / physiology
  • Neurons / cytology*
  • Neurons / metabolism
  • Neurons / ultrastructure
  • Oligonucleotide Probes / pharmacology

Substances

  • Amyloid beta-Protein Precursor
  • Antisense Elements (Genetics)
  • Culture Media
  • Oligonucleotide Probes